Rochester, MN

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 90%
3. Survival 65%
4. Genes 61%
5. Breast Neoplasms 48%
6. Mutation 48%
7. Population 48%
8. Kidney 46%
9. Mortality 44%
10. Confidence Intervals 42%
11. Proteins 42%
12. Systematic Reviews 38%
13. Heart Failure 38%
14. Lung 36%
15. Transplants 36%
16. Meta-Analysis 33%
17. Liver 33%
18. Biomarkers 33%
19. T-Lymphocytes 32%
20. Recurrence 32%
21. Incidence 32%
22. Multiple Myeloma 31%
23. Drug Therapy 31%
24. Alzheimer Disease 31%
25. Wounds and Injuries 30%
26. Clinical Trials 30%
27. Prostatic Neoplasms 29%
28. Biopsy 28%
29. Muscles 28%
30. Phenotype 28%
31. Odds Ratio 28%
32. Guidelines 28%
33. Safety 27%
34. Child 27%
35. Stroke 26%
36. Magnetic Resonance Imaging 26%
37. Brain 26%
38. Serum 25%
39. Equipment and Supplies 25%
40. Bone and Bones 24%
41. Colorectal Neoplasms 24%
42. Infections 24%
43. Exercise 24%
44. Blood Vessels 24%
45. Cohort Studies 24%
46. Randomized Controlled Trials 23%
47. Pharmaceutical Preparations 23%
48. Placebos 22%
49. Myocardial Infarction 22%
50. Liver Transplantation 22%
51. Atrial Fibrillation 22%
52. Radiotherapy 22%
53. Tomography 22%
54. DNA 21%
55. Antibodies 21%
56. Pediatrics 21%
57. Heart 21%
58. Physicians 20%
59. Neoplasm Metastasis 20%
60. Joints 20%
61. Single Nucleotide Polymorphism 20%
62. In Vitro Techniques 20%
63. Pathology 19%
64. Quality of Life 19%
65. Pancreatic Neoplasms 19%
66. Blood Pressure 19%
67. Cognitive Dysfunction 19%
68. Growth 19%
69. Fibrosis 19%
70. Elasticity Imaging Techniques 18%
71. Genome 18%
72. Gene Expression 18%
73. Health 18%
74. Adenocarcinoma 18%
75. Databases 18%
76. Morbidity 18%
77. Pain 18%
78. Seizures 18%
79. Swine 18%
80. Hypertension 18%
81. Registries 18%
82. Inflammation 17%
83. Amyloid 17%
84. Hemorrhage 17%
85. Obesity 17%
86. Ovarian Neoplasms 17%
87. Coronary Artery Disease 17%
88. Aneurysm 17%
89. Epidemiology 17%
90. Rheumatoid Arthritis 16%
91. Alleles 16%
92. Technology 16%
93. Multiple Sclerosis 16%
94. Radiation 16%
95. Costs and Cost Analysis 16%
96. Dementia 16%
97. B-Cell Chronic Lymphocytic Leukemia 16%
98. Amyloidosis 16%
99. Apoptosis 16%
100. Peptides 16%